Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D(1A) dopamine receptor: Paradoxical elevation of grooming syntax

Neuropharmacology

Volumn 37, Issue 12, 1998, Pages 1595-1602

  Clifford, Jeremiah J ^a   Tighe, Orna ^a   Croke, David T ^a   Sibley, David R ^b   Drago, John ^c   Waddington, John L ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b Human Motor Control Section   (United States)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Behavioural phenotype; Dopamine D(1A) receptor; Dopamine D1 like receptors; Grooming behaviour; Targeted gene deletion; Topography

Indexed keywords

DOPAMINE 1 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE DELETION; GROOMING; LOCOMOTION; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; TOPOGRAPHY; TRANSGENIC MOUSE;

ANIMALS; FEMALE; GROOMING; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MASTICATION; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MOTOR ACTIVITY; PHENOTYPE; RECEPTORS, DOPAMINE D1; STEREOTYPED BEHAVIOR;

EID: 0032404063     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00116-6     Document Type: Article

References (29)

1. Christensen A.V., Arnt J., Hyttel J., Larsen J.J. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. Life Science. 34:1984;1529-1540.
2. 3 dopamine receptor antagonists using an ethologically-based approach. Psychopharmacology. 136:1998;284-290.
3. 1A dopamine receptor 'knockout'. British Journal of Pharmacology. 120:1997;134P.
4. Colgan P.W. Quantitative Ethology. 1978;Wiley, New York.
5. Crawley J.N., Belknap J.K., Collins A et al. Behavioural phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology. 132:1997;107-124.
6. Cromwell H.C., Berridge K.C. Implementation of action sequences by a neostriatal site: a lesion mapping study of grooming syntax. Journal of Neuroscience. 16:1996;3444-3458.
7. 2-like agonists. Neuropharmacology. 32:1993;509-510.
8. 1-like' dopamine receptors not linked to adenylyl cyclase. British Journal of Pharmacology. 116:1995;2120-2126.
9. 1-like" dopamine receptor agonists. Pharmacology, Biochemistry and Behaviour. 58:1997;551-558.
10. 1A dopamine receptors. Proceedings of the National Academy of Science USA. 91:1994;12564-12568.
11. Drago J., Gerfen C.R., Westphal H., Steiner H. D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience. 74:1996;813-823.
12. 1A knockout mice. Molecular Pharmacology. 51:1997;6-11.
13. Jaber M., Robinson S.W., Missale C., Caron M.G. Dopamine receptors and brain function. Neuropharmacology. 35:1996;1503-1519.
14. 2+ mobilisation in Xenopus oocytes. Proceedings of the National Academy of Science USA. 87:1990;2196-2200.
15. Miner L.L., Drago J., Chamberlain P.M., Donovan D., Uhl G.R. Retained cocaine conditioned place preference in D1 receptor deficient mice. NeuroReport. 6:1995;2314-2316.
16. Molloy A.G., Waddington J.L. Dopaminergic behaviour stereospecifically promoted by the D-1 agonist R-SK&F 38393 and selectively blocked by the D-1 antagonist SCH 23390. Psychopharmacology. 82:1984;409-410.
17. 5) receptors in hippocampus. Society for Neuroscience Abstracts. 22:1996;827.
18. Murray A.M., Waddington J.L. The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction. European Journal of Pharmacology. 160:1989;377-384.
19. Neisewander J.L., Ong A., McGonigle P. Anatomical localisation of SK&F 38393-induced behaviours in rats using the irreversible monoamine receptor antagonist EEDQ. Synapse. 19:1995;134-143.
20. 2 antagonists and high doses of SCH 23390. Pharmacology, Biochemistry and Behaviour. 24:1986;837-839.
21. Undie A.S., Friedman E. Stimulation of a dopamine D-1 receptor enhances inositol phosphate formation in rat brain. Journal of Pharmacology and Experimental Therapeutics. 253:1990;987-992.
22. 1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. Journal of Neurochemistry. 62:1994;2045-2048.
23. Wachtel S.R., Brooderson R.J., White F.J. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D-1 dopamine receptor agonist SK&F 38393 in the rat. Psychopharmacology. 109:1992;41-48.
24. 2 Dopamine Receptor Interactions: Neuroscience and Psychopharmacology. 1993;271-290 Academic, London.
25. 2-like dopamine receptor systems. Niznik H.B. Dopamine Receptors and Transporters. 1994;513-538 Marcel Dekker, New York.
26. 2-like' receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 19:1995;811-831.
27. Wei L.N. Transgenic animals as new approaches in pharmacological studies. Annual Review of Pharmacology and Toxicology. 37:1997;119-241.
28. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioural responses. Cell. 79:1994;729-742.
29. Xu M., Xiu-Ti H., Cooper D.C., Moratalla R., Graybiel A.M., White F.J., Tonegawa S. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell. 79:1994;945-955.